Geron Corp Files 8-K: Officer Changes & Financials
Ticker: GERN · Form: 8-K · Filed: Oct 14, 2025 · CIK: 886744
| Field | Detail |
|---|---|
| Company | Geron Corp (GERN) |
| Form Type | 8-K |
| Filed Date | Oct 14, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: officer-change, director-change, financials
TL;DR
Geron Corp 8-K: Leadership changes, officer appointments, and financial updates filed.
AI Summary
Geron Corporation filed an 8-K on October 14, 2025, reporting on events from October 10, 2025. The filing includes information regarding the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. It also covers Regulation FD disclosures and financial statements and exhibits.
Why It Matters
This 8-K filing indicates potential shifts in Geron Corporation's leadership and provides updates on its financial and regulatory compliance, which could impact investor confidence and strategic direction.
Risk Assessment
Risk Level: medium — Changes in directors or officers, especially if unexpected, can signal internal shifts or strategic realignments that may carry inherent risks.
Key Players & Entities
- GERON CORP (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- October 10, 2025 (date) — Earliest event reported
- October 14, 2025 (date) — Date of report
FAQ
What specific officer positions were affected by the reported departures or appointments?
The filing indicates "Departure of Directors or Certain Officers" and "Appointment of Certain Officers" but does not specify the exact positions in the provided text.
Were there any significant financial statements or exhibits filed with this 8-K?
Yes, the filing explicitly lists "Financial Statements and Exhibits" as an item of information.
What is the primary business of Geron Corporation?
Geron Corporation is in the business of "PHARMACEUTICAL PREPARATIONS" as indicated by its Standard Industrial Classification code [2834].
When was Geron Corporation incorporated?
Geron Corporation was incorporated in Delaware.
What is the principal executive office address for Geron Corporation?
The principal executive offices are located at 919 E. HILLSDALE BLVD., SUITE 250, FOSTER CITY, CA 94404.
Filing Stats: 910 words · 4 min read · ~3 pages · Grade level 11.2 · Accepted 2025-10-14 08:16:36
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value GERN The Nasdaq Stock Market
Filing Documents
- gern-20251010.htm (8-K) — 29KB
- exhibit991-eltannouncement.htm (EX-99.1) — 19KB
- image_0a.jpg (GRAPHIC) — 10KB
- 0001628280-25-044862.txt ( ) — 187KB
- gern-20251010.xsd (EX-101.SCH) — 2KB
- gern-20251010_lab.xml (EX-101.LAB) — 22KB
- gern-20251010_pre.xml (EX-101.PRE) — 13KB
- gern-20251010_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On October 13, 2025, the Company issued a press release announcing four executive leadership transitions and appointments. A copy of the press release is attached as Exhibit 99.1. The information contained in Item 7.01 and in the accompanying Exhibit 99.1 to this Current Report shall be deemed to be "furnished" and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (the "Securities Act"), and shall not be incorporated by reference into any filing made by the Company with the U.S. Securities and Exchange Commission under the Securities Act or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release titled "Geron Corporation Announces Executive Leadership Transitions and Appointments", dated October 13, 2025 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document) 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GERON CORPORATION Date: October 14, 2025 By: /s/ Scott A. Samuels Name: Scott A. Samuels Title: Executive Vice President, Chief Legal Officer and Secretary 3